TWO SIGMA INVESTMENTS, LP
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1179392
NEW YORK, NY
Position in IMDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,495
New position
Shares Held
11,101
first reported quarter
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 40 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $734,488,194 across 28 Diagnostics & Research names. IMDX ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,719,301 | $558,006,729 | |
| 2 | DHR |
Danaher Corp /De/
|
452,752 | $86,240,200 | |
| 3 | CDNA |
CareDx, Inc.
|
401,987 | $11,456,629 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
48,191 | $9,311,465 | |
| 5 | MYGN |
Myriad Genetics Inc
|
1,557,727 | $8,894,621 | |
| 6 | NTRA |
Natera, Inc.
|
32,600 | $8,849,270 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
17,014 | $8,530,139 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
400,986 | $8,228,232 |
All Filings in IMDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,495 | 11,101 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||